Skip to main content
S 629 115th Congress Senate Health Drug safety, medical device, and laboratory regulation Food supply, safety, and labeling Health information and medical records Health personnel Health promotion and preventive care Livestock Meat Veterinary medicine and animal diseases

Preventing Antibiotic Resistance Act of 2017

Introduced: March 14, 2017 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 14, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 14, 2017
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Preventing Antibiotic Resistance Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to refuse a new animal drug application if the drug is a medically important antimicrobial used to treat humans and the applicant fails to demonstrate that the drug meets specified criteria for use in animals, including that: (1) the drug is effective, (2) the drug is targeted to animals at risk of developing a specific bacterial disease, (3) the drug has a defined duration of therapy, and (4) there is not a reasonable probability of risk to public health from microbial resistance to the drug.

The FDA must review the approvals of certain medically important antimicrobials approved for use in food-producing animals. Sponsors of these drugs must submit evidence to the FDA that demonstrates that their drug meets the criteria described above for approved indications. The FDA must withdraw approval for any indication for which there is insufficient evidence that the drug meets the criteria.

This bill declares that a veterinarian-client-patient relationship should ensure that medically important antimicrobials are used in food-producing animals in a manner consistent with best practices.
What's happening now March 14, 2017

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 7
All 7 Democratic 6 Republican 1
D
Reed, Jack
Rhode Island · Nov 13, 2018
 D
Booker, Cory A.
New Jersey · Nov 28, 2017
 D
Hassan, Margaret Wood
New Hampshire · Oct 30, 2017
 D
Blumenthal, Richard
Connecticut · Mar 15, 2017
 D
Gillibrand, Kirsten E.
New York · Mar 15, 2017
 D
Warren, Elizabeth
Massachusetts · Mar 15, 2017
 R
Collins, Susan M.
Maine · Mar 14, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). S. 629: Preventing Antibiotic Resistance Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-S-629/
MLA
"S. 629: Preventing Antibiotic Resistance Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-629/.
Bluebook (legal)
S. 629, 115th Cong. (2026), https://openamerica.io/bill/115-S-629/.
Markdown link
[S. 629: Preventing Antibiotic Resistance Act of 2017](https://openamerica.io/bill/115-S-629/)
Report a problem